Recent Quotes
My Watchlist
Indicators
Local Stocks
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fractyl Health, Inc. - Common Stock (NQ:GUTS)

0.5545 +0.0401 (+7.80%)
Streaming Delayed Price Updated: 12:42 PM EDT, Apr 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Fractyl Health, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
PVH Posts Q4 Results, Joins Humana, CVS Health And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
U.S. stock futures were lower this morning, with the Dow futures falling by over 100 points on Tuesday. 
Via Benzinga
Topics Stocks
News headline image
Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket ↗
Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health Receives FDA IDE Approval for the Revita® Remain-1 Pivotal Study of Weight Maintenance in Obesity after Discontinuation of GLP-1 Based Drugs
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Top 5 Health Care Stocks Which Could Rescue Your Portfolio In March ↗
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
UPDATE -- Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Durable Effects of a Single Dose of a Human GLP-1 Pancreatic Gene Therapy Transgene Compared to Semaglutide in the db/db Mouse Model of Diabetes and Obesity
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Newly Listed Obesity Player Fractyl Health Shares Encouraging Preclinical Data ↗
Fractyl Health unveils RJVA-001, a groundbreaking GLP-1 gene therapy for metabolic diseases. Promising preclinical results show durable blood sugar and weight reduction in diabetes mouse model. 
Via Benzinga
News headline image
Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Durable Effects of a Single Dose of a Human GLP-1 Pancreatic Gene Therapy Transgene Compared to Semaglutide in the db/db Mouse Model of Diabetes and Obesity
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
Pre-market stock movers are worth checking out this morning as we get into all of the biggest winners and losers for Tuesday! 
Via InvestorPlace
News headline image
Fractyl Health Appoints Samuel Conaway to Its Board of Directors, Bolstering New Product Commercial Expertise During Revita® Pivotal Clinical Trials
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Maker Of Wilson Tennis Rackets Raises $1.37 Billion In Discounted IPO ↗
Amer Sports, the maker of Wilson tennis rackets and a host of other sports equipment, raised about $1.37 billion in its initial public offering, which was priced below the previously expected $16-$18... 
Via Talk Markets
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.